A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis

  1. Vincenti, F.
  2. Fervenza, F.C.
  3. Campbell, K.N.
  4. Diaz, M.
  5. Gesualdo, L.
  6. Nelson, P.
  7. Praga, M.
  8. Radhakrishnan, J.
  9. Sellin, L.
  10. Singh, A.
  11. Thornley-Brown, D.
  12. Veronese, F.V.
  13. Accomando, B.
  14. Engstrand, S.
  15. Ledbetter, S.
  16. Lin, J.
  17. Neylan, J.
  18. Tumlin, J.
Aldizkaria:
Kidney International Reports

ISSN: 2468-0249

Argitalpen urtea: 2017

Alea: 2

Zenbakia: 5

Orrialdeak: 800-810

Mota: Artikulua

DOI: 10.1016/J.EKIR.2017.03.011 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus